Urogen Pharma (URGN) Surges 9.7%: Is This an Indication of Further Gains? [Yahoo! Finance]
UroGen Pharma Ltd. - Ordinary Shares (URGN)
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.urogen.com
Company Research
Source: Yahoo! Finance
This compares to the stock's 32.5% gain over the past four weeks. Last week, the company announced data from the phase III ENVISION study evaluating UGN-102 as a potential non-surgical treatment for patients with low-grade intermediate-risk non-muscle invasive bladder cancer. Data from the study demonstrated an 82.3% 12-month duration of response by Kaplan-Meier estimate in patients who achieved complete response at three months following the first instillation of UGN-102. This may have been driving the share price rally. This company is expected to post quarterly loss of $0.88 per share in its upcoming report, which represents a year-over-year change of +14.6%. Revenues are expected to be $23.69 million, up 12% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For
Show less
Read more
Impact Snapshot
Event Time:
URGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
URGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
URGN alerts
High impacting UroGen Pharma Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
URGN
News
- UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded WarrantsBusiness Wire
- UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants [Yahoo! Finance]Yahoo! Finance
- UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded WarrantsGlobeNewswire
- UroGen Pharma Ltd. (NASDAQ: URGN) had its price target raised by analysts at LADENBURG THALM/SH SH from $48.00 to $53.50. They now have a "buy" rating on the stock.MarketBeat
- UroGen Pharma Ltd. (NASDAQ: URGN) had its price target raised by analysts at Oppenheimer Holdings Inc. from $32.00 to $40.00. They now have an "outperform" rating on the stock.MarketBeat
URGN
Earnings
- 5/13/24 - Miss
URGN
Sec Filings
- 6/24/24 - Form SC
- 6/24/24 - Form SC
- 6/18/24 - Form 8-K
- URGN's page on the SEC website